🏛️ Verified NIH Record • Updated 2026-07-16
Trem-1 and Ultraviolet Radiation-induced Immune Suppression (NCT05020496)
Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression
🔵 Active, Not Recruiting Early Phase1 💊 Investigational Drug / Biologic Sponsor: University of Alabama at Birmingham
🩺 Plain-English Summary (8th-Grade Level)
The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.
Who can join: Review the eligibility criteria below.
Location: Whitaker Clinic — Birmingham, Alabama
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Whitaker Clinic — Birmingham, Alabama
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Skin Diseases
- Driving Time and Facial Skin Hydration Asymmetry in Florida Drivers — Orlando, Florida
- Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders — Chicago, Illinois
Explore by condition: All Skin Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.